I B Squire

1.1k total citations
24 papers, 619 citations indexed

About

I B Squire is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, I B Squire has authored 24 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 4 papers in Rheumatology and 3 papers in Molecular Biology. Recurrent topics in I B Squire's work include Heart Failure Treatment and Management (8 papers), GDF15 and Related Biomarkers (3 papers) and Cardiovascular Function and Risk Factors (3 papers). I B Squire is often cited by papers focused on Heart Failure Treatment and Management (8 papers), GDF15 and Related Biomarkers (3 papers) and Cardiovascular Function and Risk Factors (3 papers). I B Squire collaborates with scholars based in United Kingdom, United States and Canada. I B Squire's co-authors include Leong L. Ng, Joan E. Davies, Suneel Talwar, Onkar S. Dhillon, Kelvin Ng, P. Quinn, SQ Khan, W H Alwan, Paul Downie and R O'Brien and has published in prestigious journals such as The Lancet, Annals of the New York Academy of Sciences and European Heart Journal.

In The Last Decade

I B Squire

21 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I B Squire United Kingdom 13 285 220 141 118 88 24 619
Vera Paar Austria 17 349 1.2× 101 0.5× 153 1.1× 84 0.7× 81 0.9× 73 731
George Markousis‐Mavrogenis Greece 18 587 2.1× 261 1.2× 84 0.6× 100 0.8× 147 1.7× 74 1.0k
Rudin Pistulli Germany 16 352 1.2× 77 0.3× 196 1.4× 57 0.5× 76 0.9× 53 716
Cinzia Fatini Italy 15 373 1.3× 60 0.3× 76 0.5× 98 0.8× 27 0.3× 44 767
Promporn Suksaranjit United States 12 374 1.3× 77 0.3× 50 0.4× 64 0.5× 119 1.4× 31 687
Annika Jagodzinski Germany 13 254 0.9× 31 0.1× 96 0.7× 46 0.4× 61 0.7× 21 549
Ferhan Özmen Türkiye 17 776 2.7× 73 0.3× 57 0.4× 42 0.4× 48 0.5× 42 1.1k
Werner Nickl Germany 10 453 1.6× 47 0.2× 40 0.3× 56 0.5× 54 0.6× 16 599
J.-L. Dubois-Randé France 16 591 2.1× 36 0.2× 43 0.3× 92 0.8× 167 1.9× 43 950

Countries citing papers authored by I B Squire

Since Specialization
Citations

This map shows the geographic impact of I B Squire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I B Squire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I B Squire more than expected).

Fields of papers citing papers by I B Squire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I B Squire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I B Squire. The network helps show where I B Squire may publish in the future.

Co-authorship network of co-authors of I B Squire

This figure shows the co-authorship network connecting the top 25 collaborators of I B Squire. A scholar is included among the top collaborators of I B Squire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I B Squire. I B Squire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arnold, Jayanth R., Prathap Kanagala, Charley Budgeon, et al.. (2020). Prevalence of microvascular dysfunction and association with clinical outcomes in heart failure with preserved ejection fraction. European Heart Journal. 41(Supplement_2). 2 indexed citations
3.
Rodrigo, Glenn C., et al.. (2016). Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives. Heart Failure Reviews. 21(5). 635–643. 4 indexed citations
4.
5.
6.
Johnson, Miriam J., et al.. (2011). Does home oxygen benefit people with chronic heart failure?. BMJ. 342(feb04 1). d234–d234. 17 indexed citations
7.
West, Robert, Brian A. Cattle, I B Squire, et al.. (2010). Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. European Heart Journal. 32(6). 706–711. 52 indexed citations
8.
Squire, I B, P. Quinn, Hafid Narayan, et al.. (2010). Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP. Heart. 96(11). 831–837. 4 indexed citations
9.
Khan, SQ, Kelvin Ng, Onkar S. Dhillon, et al.. (2009). Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. European Heart Journal. 30(9). 1057–1065. 173 indexed citations
10.
Talwar, Suneel, I B Squire, Paul Downie, et al.. (2000). Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clinical Science. 99(1). 83–88. 31 indexed citations
11.
Talwar, Suneel, I B Squire, Paul Downie, et al.. (2000). Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clinical Science. 99(1). 83–83. 62 indexed citations
12.
13.
Hughes, D.J., Suneel Talwar, I B Squire, Joanna E. Davies, & Leong L. Ng. (1999). An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. Clinical Science. 96(4). 373–373. 23 indexed citations
14.
Squire, I B, et al.. (1996). Differing Early Blood Pressure and Renin-Angiotensin System Responses to the First Dose of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 27(5). 657–666. 32 indexed citations
15.
Squire, I B, K. R. Lees, William Pryse‐Phillips, Andrew Kertesz, & John Bamford. (1996). The Effects of Lifarizine in Acute Cerebral Infarction: A Pilot Safety Study. Cerebrovascular Diseases. 6(3). 156–160. 38 indexed citations
16.
Squire, I B, Kennedy R. Lees, William Pryse‐Phillips, Andrew Kertesz, & John Bamford. (1995). Efficacy and Tolerability of Lifarizine in Acute Ischemic Stroke. A Pilot Study. Annals of the New York Academy of Sciences. 765(1). 317–318. 18 indexed citations
17.
Squire, I B, et al.. (1994). Anticardiolipin antibodies in an unselected stroke population. The Lancet. 344(8920). 452–456. 85 indexed citations
18.
Morris, A. D., Donald G. Grosset, I B Squire, et al.. (1994). Streptokinase for the Treatment of Acute Cerebral Infarction: A Placebo Controlled Pilot Study. Clinical Science. 86(s30). 4P–4P. 3 indexed citations
19.
Squire, I B, et al.. (1994). Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.. British Journal of Clinical Pharmacology. 38(2). 117–123. 14 indexed citations
20.
Morris, Andrew D., Donald G. Grosset, I B Squire, et al.. (1993). The experiences of an acute stroke unit--implications for multicentre acute stroke trials.. Journal of Neurology Neurosurgery & Psychiatry. 56(4). 352–355. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vera Paar Breakdown of academic impact, for papers by George Markousis‐Mavrogenis Breakdown of academic impact, for papers by Rudin Pistulli Breakdown of academic impact, for papers by Cinzia Fatini Breakdown of academic impact, for papers by Promporn Suksaranjit Breakdown of academic impact, for papers by Annika Jagodzinski Breakdown of academic impact, for papers by Ferhan Özmen Breakdown of academic impact, for papers by Werner Nickl Breakdown of academic impact, for papers by J.-L. Dubois-Randé
Rankless by CCL
2026